Building an upstream engine for novel target discovery
Foreseen’s platform strategy focuses on discovering highly differentiated targets at the source of drug and diagnostic innovation.
Foreseen Biotech was founded to address a central bottleneck in drug discovery: the shortage of novel, translatable and biologically validated targets.
The company’s platform brings together high-quality proteomic data generation, integrated omics analytics and disease-mechanism interpretation to support target discovery from the earliest stage.
By combining internal research with co-development and external partnerships, Foreseen aims to translate differentiated biology into biologics, ADC and diagnostic opportunities.
Collaboration & media inquiries
For additional information about the platform, pipeline or partnership opportunities, submit an inquiry through the contact page.
Contact Foreseen